• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

Archives for December 2015

IP Summit: Changes In Patent System, Intermediary Liability And The Future Of IP

04/12/2015 by Monika Ermert for Intellectual Property Watch Leave a Comment

The stretch run for Europe’s Unitary Patent System (UPS) again took centre stage at the Premier Cercle IP Summit 2015 in Berlin yesterday. Eyes are on Germany for the ratification of the UPS. Cornelia Rudloff-Schäffer, president of the German Patent Office, in the keynote speech assured the 300 hundred participants Germany was preparing for the new system and called out to industry to prepare for the change, saying: “Check your portfolio now.”

Filed Under: IP Policies, Language, Themes, Venues, Copyright Policy, Enforcement, English, Europe, Innovation/ R&D, Patents/Designs/Trade Secrets, Regional Policy, Trademarks/Geographical Indications/Domains

Colombia Asked To Declare Excessive Price For Cancer Drug Contrary To Public Interest, Grounds For Compulsory License

03/12/2015 by Intellectual Property Watch 11 Comments

Colombia has a decision to make. A full year has passed from the November 24, 2014 request by iFarma, Misión Salud and CIMUN for a declaration of the public interest regarding the cancer drug imatinib (marketed by Novartis as Gleevec/Glivec), the first step on the path toward a compulsory license in Colombia. Thus far, Colombia’s Ministry of Health and Social Protection has failed to act one way or another, leaving patients in limbo and the government at the mercy of a Swiss pharmaceutical giant that reported revenue of over $57.9 Billion USD in 2013, write James Love and Andrew S. Goldman.

Filed Under: Features, Inside Views, IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, English, Finance, Health & IP, Human Rights, Latin America/Caribbean, Patents/Designs/Trade Secrets, Regional Policy, WHO

Speakers At WIPO Diverge On Patents-Access Relationship; Biologics A Challenge For Generics

03/12/2015 by Catherine Saez, Intellectual Property Watch 3 Comments

A seminar on patents and availability of medicines in developing countries yesterday considered whether patents constitute a barrier to access. For the private sector, patents are essential to the innovation system, for others they maintain high prices and should be licensed for easier access. Beyond patents, biologics seem to be taking over the pharmaceutical industry, and the complexity of manufacturing biosimilars might well leave traditional generic manufacturers by the wayside.

Separately, a side event at WIPO looked at IP management strategies in private-public partnerships in agriculture and health technologies.

Filed Under: IP Policies, Language, Themes, Venues, Biodiversity/Genetic Resources/Biotech, English, Health & IP, Innovation/ R&D, Lobbying, Patents/Designs/Trade Secrets, WIPO

New UNDP-Blind Union Report Helps Asia-Pacific Nations Ratify Marrakesh Treaty

03/12/2015 by Catherine Saez, Intellectual Property Watch 1 Comment

The United Nations Development Programme joined forces with the World Blind Union to prepare a new report aimed at facilitating Asia-Pacific countries’ ratification of a treaty designed to help visually-impaired people access special format books.

Filed Under: IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Copyright Policy, English, Human Rights, Information and Communications Technology/ Broadcasting, Innovation/ R&D, WIPO

New Proposal At WIPO SCCR To Explore Use Of Copyrighted Works In Digital Environment

02/12/2015 by Catherine Saez, Intellectual Property Watch 1 Comment

Latin American and Caribbean countries have tabled a new proposal for next week’s meeting of the World Intellectual Property Organization committee on copyright. The proposal calls for analysing copyright related to the digital environment.

Filed Under: IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Copyright Policy, English, Information and Communications Technology/ Broadcasting, WIPO

German Intelligence Services Oversight Body Files Action Against Government

02/12/2015 by Intellectual Property Watch Leave a Comment

For the first time in its history, the G10 Commission, an oversight body over the German Intelligence Services, will go to court to challenge decisions by the German government and the services, German Public Broadcasting and the Süddeutsche Zeitung revealed last night.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Copyright Policy, English, Europe, Human Rights, IP Law, Regional Policy, Trademarks/Geographical Indications/Domains

Impact Of The TPP On The Pharma Industry

02/12/2015 by Intellectual Property Watch Leave a Comment

The final text of the Trans-Pacific Partnership confirms beyond doubt the apprehensions expressed by civil society, academia and the generic industry about new barriers to access to medicines. The TPP has done away with several flexibilities provided under the TRIPS Agreement and the Doha Declaration on Public Health. Though the text mentions “nothing in this [IPR] Chapter limits a Party’s rights and obligations under Article 31 of the TRIPS Agreement,” the TPP Investment Chapter overrides these flexibilities, says D G Shah.

Filed Under: Features, Inside Views, IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Bilateral/Regional Negotiations, English, Health & IP, Innovation/ R&D, Patents/Designs/Trade Secrets, WTO/TRIPS

ARIPO Continues To Build Member State IP Capacities

02/12/2015 by Hillary Muheebwa for Intellectual Property Watch Leave a Comment

The African Regional Intellectual Property Organization (ARIPO) recently held two top organ meetings in Lusaka, Zambia, to debate the organisation’s strategic plan for 2016-2020.

Filed Under: IP Policies, Language, Themes, Venues, Africa, Copyright Policy, Development, English, Patents/Designs/Trade Secrets, Regional Policy, Technical Cooperation/ Technology Transfer, Trademarks/Geographical Indications/Domains, WIPO

European Court Of Human Rights Finds Turkey Violated Freedom Of Expression In YouTube Blocking

01/12/2015 by Intellectual Property Watch Leave a Comment

Ten sites allegedly disrespectful to Kemal Attaturk, founder of modern Turkey, were enough for the courts in Turkey to ban a whole platform – YouTube – from 2008 until the end of 2010. But a ruling of the European Court of Human Rights today declared the blanket blocking a violation of the right to receive and impart information freely, protected under Article 10 of the European Convention on Human Rights.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Copyright Policy, Enforcement, English, Europe, Human Rights, IP Law, Information and Communications Technology/ Broadcasting, Other International Orgs, Regional Policy, Trademarks/Geographical Indications/Domains

US Congressional Study Finds Excessive Profit-Seeking In USD84K Hepatitis Drug Sovaldi

01/12/2015 by Intellectual Property Watch Leave a Comment

Two bipartisan United States senators today released the results of an 18-month investigation into the US$84,000 price of the Sovaldi hepatitis C drug, finding the pricing and marketing strategy was aimed at maximizing revenue at the expense of access and affordability. The new report also shows the high impact on US government drug procurement programs and other data.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, English, Finance, Health & IP, Human Rights, North America, Patents/Designs/Trade Secrets, Regional Policy

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2025 · Global Policy Reporting